Scarica l'app Stockscreener
1.80
6.51%
0.11
Precedente Chiudi:
$1.69
Aprire:
$1.69
Volume 24 ore:
267.37K
Relative Volume:
0.43
Capitalizzazione di mercato:
$56.00M
Reddito:
$1.05M
Utile/perdita netta:
$-48.82M
Rapporto P/E:
-0.9836
EPS:
-1.83
Flusso di cassa netto:
$-47.49M
1 W Prestazione:
+16.88%
1M Prestazione:
+30.43%
6M Prestazione:
+32.35%
1 anno Prestazione:
-77.47%
Intervallo 1D:
$1.65
$1.85
Intervallo di 1 settimana:
$1.54
$1.85
Portata 52W:
$1.06
$8.64
Actinium Pharmaceuticals Inc Stock (ATNM) Company Profile
Nome
Actinium Pharmaceuticals Inc
Settore
Industria
Telefono
646-767-3870
Indirizzo
275 Madison Avenue, 7th Floor, New York, NY
Confronta ATNM con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ATNM
Actinium Pharmaceuticals Inc
|
1.795 | 49.29M | 1.05M | -48.82M | -47.49M | -1.83 |
|
ONC
Beone Medicines Ltd Adr
|
256.67 | 26.69B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
450.42 | 114.81B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.27 | 41.83M | 0 | 0 | 0 | 0.00 |
|
VRNA
Verona Pharma Plc Adr
|
83.47 | 6.60B | 0 | -153.72M | -103.81M | -2.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
495.43 | 65.36B | 14.09B | 4.50B | 2.96B | 39.28 |
Actinium Pharmaceuticals Inc Stock (ATNM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-08-07 | Downgrade | B. Riley Securities | Buy → Neutral |
| 2024-05-14 | Iniziato | Stephens | Overweight |
| 2023-09-06 | Iniziato | HSBC Securities | Buy |
| 2023-02-21 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2022-09-08 | Iniziato | Cantor Fitzgerald | Overweight |
| 2022-08-25 | Iniziato | B. Riley Securities | Buy |
| 2020-11-05 | Iniziato | Alliance Global Partners | Buy |
| 2017-12-06 | Iniziato | B. Riley FBR, Inc. | Buy |
| 2017-10-23 | Ripresa | ROTH Capital | Buy |
| 2017-09-14 | Iniziato | Maxim Group | Buy |
| 2016-08-25 | Iniziato | ROTH Capital | Buy |
| 2016-02-29 | Iniziato | H.C. Wainwright | Buy |
| 2015-10-15 | Iniziato | FBR Capital | Outperform |
| 2014-10-01 | Iniziato | MLV & Co | Buy |
| 2014-07-22 | Iniziato | Canaccord Genuity | Buy |
Mostra tutto
Actinium Pharmaceuticals Inc Borsa (ATNM) Ultime notizie
ATNM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Investors of Actinium Pharmaceuticals, Inc. to Contact the Firm Today! - ACCESS Newswire
Actinium Pharmaceuticals, Inc. (NYSE:ATNM) Shares Purchased by Deutsche Bank AG - Defense World
Northern Trust Corp Grows Stock Holdings in Actinium Pharmaceuticals, Inc. (NYSE:ATNM) - Defense World
Class Action Filed Against Actinium Pharmaceuticals, Inc. (ATNM)May 27, 2025 Deadline to JoinContact Levi & Korsinsky - PR Newswire
Shareholders of Actinium Pharmaceuticals, Inc. (ATNM): Protect Your Rights Before May 27, 2025Contact Levi & Korsinsky - ACCESS Newswire
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Actinium - Business Wire
ATNM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
FINAL REMINDER ATNM DEADLINE: Bronstein, Gewirtz & Grossman LLC Alerts Actinium Pharmaceuticals, Inc. Investors to Participate in the Class Action Lawsuit - ACCESS Newswire
2025-05-26 | Lost Money on Actinium Pharmaceuticals, Inc. (ATNM)? Urged to Join Class Action Before May 27, 2025Contact Levi & Korsinsky | NYSEAM:ATNM | Press Release - Stockhouse
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Actinium Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming DeadlinesATNM - Eastern Progress
ATNM Deadline: ATNM Investors with Losses in Excess of $100K Hav - GuruFocus
ATNM Deadline: ATNM Investors with Losses in Excess of $100K Have Opportunity to Lead Actinium Pharmaceuticals, Inc. Securities Fraud Lawsuit - Morningstar
Class Action Lawsuit Filed: Actinium Pharmaceuticals, Inc. (ATNM)Join by May 27, 2025Contact Levi & Korsinsky - Stockhouse
Lost Money on Actinium Pharmaceuticals, Inc. (ATNM)? Contact Levi & Korsinsky to Join Class Action Before May 27, 2025 - ACCESS Newswire
ATNM DEADLINE NOTICE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Actinium Pharmaceuticals, ... - Eagle-Tribune
ATNM DEADLINE NOTICE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, - GlobeNewswire
ATNM DEADLINE NOTICE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Actinium Pharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important May 27 Deadline in Securities Class Action – ATNM - GlobeNewswire Inc.
Levi & Korsinsky Notifies Actinium Pharmaceuticals, Inc. (ATNM) Shareholders of Class Action Lawsuit and May 27, 2025 Deadline - ACCESS Newswire
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Actinium - StreetInsider
ATNM Deadline: Rosen Law Firm Urges Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights - The Joplin Globe
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 27, 2025 in Actinium LawsuitATNM - The Malaysian Reserve
ATNM DEADLINE ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, - GlobeNewswire
Shareholders that lost money on Actinium Pharmaceuticals, Inc. (ATNM) Urged to Join Class ... - Bluefield Daily Telegraph
Shareholders that lost money on Actinium Pharmaceuticals, - GlobeNewswire
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Actinium - marketscreener.com
Class Action Filed Against Actinium Pharmaceuticals, Inc. (ATNM) Over Securities ViolationsContact Levi & Korsinsky Today - ACCESS Newswire
Actinium Pharmaceuticals, Inc. (NYSE: ATNM) Investor Alert: Deadline in Lawsuit on May 26, 2025 - openPR.com
Lost Money on Actinium Pharmaceuticals, Inc. (ATNM)? Urged to Join Class Action Before May 27, 2025Contact Levi & Korsinsky - ACCESS Newswire
Investors in Actinium Pharmaceuticals, Inc. (ATNM): Protect Your RightsContact Levi & Korsinsky Before May 27, 2025 - ACCESS Newswire
ATNM INVESTOR ALERT: Kirby McInerney LLP Reminds Actinium Pharmaceuticals, Inc. Investors of Looming Lead Plaintiff Deadline in Class Action Lawsuit - Louisiana First News
Contact The Gross Law Firm by May 27, 2025 Deadline to Join Class Action Against Actinium Pharmaceuticals, Inc. (ATNM) - The Malaysian Reserve
ATNM Lawsuit Alert! Class Action Lawsuit Against Actinium Pharmaceuticals - TipRanks
Investors in Actinium Pharmaceuticals, Inc. Should Contact Levi & Korsinsky Before May 27, 2025 to Discuss Your RightsATNM - marketscreener.com
ATNM INVESTOR ALERT: Kirby McInerney LLP Reminds Actinium - GlobeNewswire
Investor Alert: Deadline Approaching to Join Actinium Pharmaceuticals, Inc. (ATNM) Class ActionContact Levi & Korsinsky - Louisiana First News
ROSEN, A TOP RANKED LAW FIRM, Encourages Actinium - GlobeNewswire
ATNM LAWSUIT ALERT: Levi & Korsinsky Notifies Actinium Pharmaceuticals, Inc. Investors of a ... - Bluefield Daily Telegraph
ATNM LAWSUIT ALERT: Levi & Korsinsky Notifies Actinium - GlobeNewswire
Dimensional Fund Advisors LP Cuts Stock Position in Actinium Pharmaceuticals, Inc. (NYSE:ATNM) - Defense World
ATNM Investors Have the Opportunity to Lead the Actinium Securities Fraud Lawsuit with Faruqi & Faruqi, LLP - GlobeNewswire
ATNM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Actinium Pharmaceuticals, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Head-To-Head Survey: Xenetic Biosciences (NASDAQ:XBIO) & Actinium Pharmaceuticals (NYSE:ATNM) - Defense World
Did You Lose Money on Actinium Pharmaceuticals, Inc. (ATNM)? Levi & Korsinsky Urges Investors to Act Before May 27, 2025 - ACCESS Newswire
ATNM Investors Have Opportunity to Lead Actinium Pharmaceuticals, Inc. Securities Fraud Lawsuit - Morningstar
Investors who lost money on Actinium Pharmaceuticals, - GlobeNewswire
Actinium Pharmaceuticals, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before May 27, 2025 to Discuss Your RightsATNM - WV News
HC Wainwright Has Pessimistic Outlook of ATNM Q2 Earnings - Defense World
Recover Investment Losses: Levi & Korsinsky Files Class Action Against Actinium Pharmaceuticals, Inc. (ATNM) - ACCESS Newswire
Actinium Faces Derivative Suit Over FDA Application Claims - Law360
Actinium Pharmaceuticals Inc Azioni (ATNM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.30%
3.35%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):